Broomfield, CO, United States of America

Hongmei Huang


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Hongmei Huang in Cancer Treatment

Introduction: Hongmei Huang, based in Broomfield, Colorado, is a prominent inventor recognized for her significant contributions to cancer treatment through her innovative research and patented technologies. With a total of two patents, her work particularly emphasizes the enhancement of therapies aimed at combating cancer.

Latest Patents: Hongmei Huang holds two notable patents focused on materials and methods to potentiate cancer treatment. These patents consist of compounds that inhibit DNA-dependent protein kinase (DNA-PK), comprehensive compositions of these compounds, and methodologies designed to inhibit the biological activity of DNA-PK. Additionally, her inventions include methods to sensitize cells to agents that induce DNA lesions, ultimately serving to enhance the effectiveness of cancer treatments.

Career Highlights: Throughout her career, Hongmei Huang has made significant strides in the pharmaceutical industry. She has been associated with reputable companies such as Icos Corporation and Luitpold Pharmaceuticals, Inc.. Her role in these organizations has contributed to the advancement of innovative cancer therapies and treatments.

Collaborations: In her journey as an inventor, Hongmei Huang has collaborated with esteemed professionals, including James W Halbrook and Edward A Kesicki. These partnerships have facilitated a rich exchange of ideas and expertise, further driving the innovation in her field of work.

Conclusion: Hongmei Huang exemplifies the spirit of innovation with her groundbreaking work in cancer treatment. Her patents represent a significant advancement in the fight against cancer, showcasing her dedication to improving patient outcomes. As she continues her work, her contributions will undoubtedly inspire future advancements in the medical and pharmaceutical industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…